FORE-SIGHT Tissue Oximeter During Cardiac Surgery
Status: | Recruiting |
---|---|
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 6/14/2018 |
Start Date: | May 2014 |
End Date: | December 2018 |
Contact: | Jennifer Scovotti, M.A. |
Email: | jscovotti@mednet.ucla.edu |
Phone: | 310.206.4484 |
CAS Medical Systems FORE-SIGHT Elite Tissue Oximeter During Cardiac Surgery
The purpose of this study is to measure cerebral and lower extremity oximetry on patients
during cardiac surgery.
during cardiac surgery.
The purpose of this research study is to collect data from a tissue oximeter device that
measures brain oxygen saturation simultaneous with data from the same device that monitors
skeletal muscle during cardiac surgery. This monitoring will allow for continuous,
non-invasive, and earlier assessment of perfusion abnormalities/hypoperfusion.
Two sensors from the FORE-SIGHT Elite monitor will be placed on the forehead above the
eyebrows and two additional sensors will be placed on the leg muscles. Data from the
FORE-SIGHT Elite monitor will be recorded in addition to clinical and demographic data, which
is standard of care during the procedure, for research purposes to look at factors associated
with desaturations.
measures brain oxygen saturation simultaneous with data from the same device that monitors
skeletal muscle during cardiac surgery. This monitoring will allow for continuous,
non-invasive, and earlier assessment of perfusion abnormalities/hypoperfusion.
Two sensors from the FORE-SIGHT Elite monitor will be placed on the forehead above the
eyebrows and two additional sensors will be placed on the leg muscles. Data from the
FORE-SIGHT Elite monitor will be recorded in addition to clinical and demographic data, which
is standard of care during the procedure, for research purposes to look at factors associated
with desaturations.
Inclusion Criteria:
- Subjects where cerebral oximetry is monitored during their surgery
Exclusion Criteria:
- Birthmarks, tattoos, or other skin abnormalities that FORE-SIGHT Sensors cannot avoid
We found this trial at
1
site
Los Angeles, California 90095
Principal Investigator: Kimberly Howard-Quijano, M.D.
Click here to add this to my saved trials